Digital pathology in nephrology clinical trials, research, and pathology practice

Laura Barisoni-Thomas, Jeffrey B. Hodgin

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Purpose of review In this review, we will discuss (i) how the recent advancements in digital technology and computational engineering are currently applied to nephropathology in the setting of clinical research, trials, and practice; (ii) the benefits of the new digital environment; (iii) how recognizing its challenges provides opportunities for transformation; and (iv) nephropathology in the upcoming era of kidney precision and predictive medicine. Recent findings Recent studies highlighted how new standardized protocols facilitate the harmonization of digital pathology database infrastructure and morphologic, morphometric, and computer-aided quantitative analyses. Digital pathology enables robust protocols for clinical trials and research, with the potential to identify previously underused or unrecognized clinically useful parameters. The integration of digital pathology with molecular signatures is leading the way to establishing clinically relevant morpho-omic taxonomies of renal diseases. Summary The introduction of digital pathology in clinical research and trials, and the progressive implementation of the modern software ecosystem, opens opportunities for the development of new predictive diagnostic paradigms and computer-aided algorithms, transforming the practice of renal disease into a modern computational science.

Original languageEnglish (US)
Pages (from-to)450-459
Number of pages10
JournalCurrent Opinion in Nephrology and Hypertension
Volume26
Issue number6
DOIs
StatePublished - Nov 1 2017

Fingerprint

Clinical Pathology
Nephrology
Clinical Trials
Pathology
Kidney
Research
Precision Medicine
Molecular Pathology
Ecosystem
Software
Databases
Technology

Keywords

  • computational disease
  • convolutional neural network
  • deep learning
  • focal segmental glomerulosclerosis
  • morphometry
  • nephrotic syndrome
  • podocytes
  • structural feature extraction

ASJC Scopus subject areas

  • Internal Medicine
  • Nephrology

Cite this

Digital pathology in nephrology clinical trials, research, and pathology practice. / Barisoni-Thomas, Laura; Hodgin, Jeffrey B.

In: Current Opinion in Nephrology and Hypertension, Vol. 26, No. 6, 01.11.2017, p. 450-459.

Research output: Contribution to journalReview article

@article{f2a515f1c46d43dfbc4c49af7187f696,
title = "Digital pathology in nephrology clinical trials, research, and pathology practice",
abstract = "Purpose of review In this review, we will discuss (i) how the recent advancements in digital technology and computational engineering are currently applied to nephropathology in the setting of clinical research, trials, and practice; (ii) the benefits of the new digital environment; (iii) how recognizing its challenges provides opportunities for transformation; and (iv) nephropathology in the upcoming era of kidney precision and predictive medicine. Recent findings Recent studies highlighted how new standardized protocols facilitate the harmonization of digital pathology database infrastructure and morphologic, morphometric, and computer-aided quantitative analyses. Digital pathology enables robust protocols for clinical trials and research, with the potential to identify previously underused or unrecognized clinically useful parameters. The integration of digital pathology with molecular signatures is leading the way to establishing clinically relevant morpho-omic taxonomies of renal diseases. Summary The introduction of digital pathology in clinical research and trials, and the progressive implementation of the modern software ecosystem, opens opportunities for the development of new predictive diagnostic paradigms and computer-aided algorithms, transforming the practice of renal disease into a modern computational science.",
keywords = "computational disease, convolutional neural network, deep learning, focal segmental glomerulosclerosis, morphometry, nephrotic syndrome, podocytes, structural feature extraction",
author = "Laura Barisoni-Thomas and Hodgin, {Jeffrey B.}",
year = "2017",
month = "11",
day = "1",
doi = "10.1097/MNH.0000000000000360",
language = "English (US)",
volume = "26",
pages = "450--459",
journal = "Current Opinion in Nephrology and Hypertension",
issn = "1062-4821",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Digital pathology in nephrology clinical trials, research, and pathology practice

AU - Barisoni-Thomas, Laura

AU - Hodgin, Jeffrey B.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Purpose of review In this review, we will discuss (i) how the recent advancements in digital technology and computational engineering are currently applied to nephropathology in the setting of clinical research, trials, and practice; (ii) the benefits of the new digital environment; (iii) how recognizing its challenges provides opportunities for transformation; and (iv) nephropathology in the upcoming era of kidney precision and predictive medicine. Recent findings Recent studies highlighted how new standardized protocols facilitate the harmonization of digital pathology database infrastructure and morphologic, morphometric, and computer-aided quantitative analyses. Digital pathology enables robust protocols for clinical trials and research, with the potential to identify previously underused or unrecognized clinically useful parameters. The integration of digital pathology with molecular signatures is leading the way to establishing clinically relevant morpho-omic taxonomies of renal diseases. Summary The introduction of digital pathology in clinical research and trials, and the progressive implementation of the modern software ecosystem, opens opportunities for the development of new predictive diagnostic paradigms and computer-aided algorithms, transforming the practice of renal disease into a modern computational science.

AB - Purpose of review In this review, we will discuss (i) how the recent advancements in digital technology and computational engineering are currently applied to nephropathology in the setting of clinical research, trials, and practice; (ii) the benefits of the new digital environment; (iii) how recognizing its challenges provides opportunities for transformation; and (iv) nephropathology in the upcoming era of kidney precision and predictive medicine. Recent findings Recent studies highlighted how new standardized protocols facilitate the harmonization of digital pathology database infrastructure and morphologic, morphometric, and computer-aided quantitative analyses. Digital pathology enables robust protocols for clinical trials and research, with the potential to identify previously underused or unrecognized clinically useful parameters. The integration of digital pathology with molecular signatures is leading the way to establishing clinically relevant morpho-omic taxonomies of renal diseases. Summary The introduction of digital pathology in clinical research and trials, and the progressive implementation of the modern software ecosystem, opens opportunities for the development of new predictive diagnostic paradigms and computer-aided algorithms, transforming the practice of renal disease into a modern computational science.

KW - computational disease

KW - convolutional neural network

KW - deep learning

KW - focal segmental glomerulosclerosis

KW - morphometry

KW - nephrotic syndrome

KW - podocytes

KW - structural feature extraction

UR - http://www.scopus.com/inward/record.url?scp=85030751839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030751839&partnerID=8YFLogxK

U2 - 10.1097/MNH.0000000000000360

DO - 10.1097/MNH.0000000000000360

M3 - Review article

VL - 26

SP - 450

EP - 459

JO - Current Opinion in Nephrology and Hypertension

JF - Current Opinion in Nephrology and Hypertension

SN - 1062-4821

IS - 6

ER -